DK0928183T3 - Use of 1-hydroxy-2-pyridones for the treatment of seborrhoic dermatitis - Google Patents

Use of 1-hydroxy-2-pyridones for the treatment of seborrhoic dermatitis

Info

Publication number
DK0928183T3
DK0928183T3 DK97910294T DK97910294T DK0928183T3 DK 0928183 T3 DK0928183 T3 DK 0928183T3 DK 97910294 T DK97910294 T DK 97910294T DK 97910294 T DK97910294 T DK 97910294T DK 0928183 T3 DK0928183 T3 DK 0928183T3
Authority
DK
Denmark
Prior art keywords
pyridones
hydroxy
treatment
seborrhoic dermatitis
seborrhoic
Prior art date
Application number
DK97910294T
Other languages
Danish (da)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0928183T3 publication Critical patent/DK0928183T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
DK97910294T 1996-09-27 1997-09-16 Use of 1-hydroxy-2-pyridones for the treatment of seborrhoic dermatitis DK0928183T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (en) 1996-09-27 1996-09-27 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
PCT/EP1997/005070 WO1998013009A2 (en) 1996-09-27 1997-09-16 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis

Publications (1)

Publication Number Publication Date
DK0928183T3 true DK0928183T3 (en) 2002-04-02

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97910294T DK0928183T3 (en) 1996-09-27 1997-09-16 Use of 1-hydroxy-2-pyridones for the treatment of seborrhoic dermatitis

Country Status (32)

Country Link
EP (1) EP0928183B1 (en)
JP (2) JP2001500884A (en)
KR (1) KR100494207B1 (en)
CN (1) CN1104231C (en)
AR (1) AR008860A1 (en)
AT (1) ATE209891T1 (en)
AU (1) AU716208B2 (en)
BG (1) BG64365B1 (en)
BR (1) BR9711575A (en)
CA (1) CA2267165C (en)
CY (1) CY2362B1 (en)
CZ (1) CZ291485B6 (en)
DE (2) DE19639818A1 (en)
DK (1) DK0928183T3 (en)
ES (1) ES2167721T3 (en)
HK (1) HK1022267A1 (en)
HU (1) HU226955B1 (en)
ID (1) ID21874A (en)
IL (1) IL129141A0 (en)
MA (1) MA24333A1 (en)
MY (1) MY125674A (en)
NO (1) NO312492B1 (en)
NZ (1) NZ334850A (en)
OA (1) OA11028A (en)
PL (1) PL188033B1 (en)
PT (1) PT928183E (en)
RS (1) RS49801B (en)
TR (1) TR199900662T2 (en)
TW (1) TW519491B (en)
UA (1) UA57754C2 (en)
WO (1) WO1998013009A2 (en)
ZA (1) ZA978640B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639816A1 (en) 1996-09-27 1998-04-02 Hoechst Ag Antifungal agents with high drug release
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ES2402041T3 (en) 2007-08-31 2013-04-26 Janssen Pharmaceutica, N.V. Combinations of imazalil and hydroxypyridones
US20100305161A1 (en) 2007-11-30 2010-12-02 Jan Peter Hendrik Bosselaers Combinations of fungicidal azoles and pyrion compounds
CN101932243B (en) 2008-02-06 2014-04-23 詹森药业有限公司 Combinations of phenylpyrroles and pyrion compounds
EP2587920B1 (en) 2010-07-01 2016-08-10 Janssen Pharmaceutica, N.V. Antimicrobial combinations of pyrion compounds with polyethyleneimines
US8609637B2 (en) * 2010-12-02 2013-12-17 The University Of Kansas Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1H)-one and derivatives thereof
JP5528629B2 (en) * 2011-07-19 2014-06-25 リジェンティス株式会社 A polyphosphoric acid composition containing polyphosphoric acid extracted from yeast, a salt of polyphosphoric acid, or a solvate of polyphosphoric acid, and a method for producing the same.
FR2983858B1 (en) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique NOVEL INHIBITORY COMPOUNDS OF LIPOGENESIS
CN104744359B (en) * 2015-03-06 2017-10-10 上药康丽(常州)药业有限公司 A kind of process for purification of Ciclopirox

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (en) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Cosmetic preparations
NL8601762A (en) * 1986-07-07 1988-02-01 Bouke Jan Lange METHOD FOR CLEANING AND CONDITIONING AND ANY MEDICINAL TREATMENT OF HAIR AND SCALP, A TWO-PHASE SHAMPOO USABLE FOR THIS PURPOSE AND PACKAGING FOR IT.
BR9307019A (en) * 1992-09-08 1999-02-23 Procter & Gamble Substantially mild colorless shampoo composition
DE4333893A1 (en) * 1993-10-05 1995-04-06 Hoechst Ag Cosmetic preparations
FR2722689B1 (en) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique NOVEL COMBINATION PRODUCT COMPRISING AN ANTIFUNGAL AGENT AND CROTAMITON AS A POTENTIALIZER OF THE ACTIVITY OF THE ANTIFUNGAL AGENT, AND DERMATOLOGICAL AND / OR COSMETIC COMPOSITIONS COMPRISING THE SAME

Also Published As

Publication number Publication date
ZA978640B (en) 1998-03-27
AU716208B2 (en) 2000-02-24
ID21874A (en) 1999-08-05
CY2362B1 (en) 2004-06-04
OA11028A (en) 2003-03-06
WO1998013009A3 (en) 1998-05-14
DE59705697D1 (en) 2002-01-17
TW519491B (en) 2003-02-01
AR008860A1 (en) 2000-02-23
EP0928183B1 (en) 2001-12-05
HUP9903811A1 (en) 2000-04-28
CN1231595A (en) 1999-10-13
CA2267165C (en) 2003-12-16
NZ334850A (en) 2001-02-23
TR199900662T2 (en) 1999-06-21
KR20000048613A (en) 2000-07-25
JP2001500884A (en) 2001-01-23
JP2006176540A (en) 2006-07-06
NO312492B1 (en) 2002-05-21
RS49801B (en) 2008-06-05
BG103260A (en) 2000-01-31
CA2267165A1 (en) 1998-04-02
YU13499A (en) 2001-09-28
HU226955B1 (en) 2010-03-29
WO1998013009A2 (en) 1998-04-02
CZ107599A3 (en) 1999-06-16
HUP9903811A3 (en) 2001-11-28
PL188033B1 (en) 2004-11-30
AU4774697A (en) 1998-04-17
MA24333A1 (en) 1998-04-01
ATE209891T1 (en) 2001-12-15
PT928183E (en) 2002-05-31
HK1022267A1 (en) 2000-08-04
UA57754C2 (en) 2003-07-15
IL129141A0 (en) 2000-02-17
ES2167721T3 (en) 2002-05-16
CN1104231C (en) 2003-04-02
NO991460D0 (en) 1999-03-25
BG64365B1 (en) 2004-12-30
PL332603A1 (en) 1999-09-27
MY125674A (en) 2006-08-30
CZ291485B6 (en) 2003-03-12
DE19639818A1 (en) 1998-04-02
NO991460L (en) 1999-03-25
BR9711575A (en) 1999-08-24
EP0928183A2 (en) 1999-07-14
KR100494207B1 (en) 2005-06-13

Similar Documents

Publication Publication Date Title
DK0830864T3 (en) Combination therapy for the treatment of psychoses
DK1063990T3 (en) Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
DK0861081T3 (en) Use of epinastine for the treatment of pain
DK0914103T3 (en) Treatment of hemoglobinopathy
DK0941089T3 (en) Use of anti-microtubule agents for the treatment or prophylaxis of multiple sclerosis
DK1077940T3 (en) 4-Phenylpiperidines for the treatment of pruritic dermatoses
DK0937055T3 (en) Process for the preparation of d, I-alpha-tocopherol
DK0752870T3 (en) Use of Mycobacterium for the treatment of tumors
DK199800837A (en) Installations for the treatment of subjects
DK0928183T3 (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrhoic dermatitis
DK1042228T3 (en) Process for the treatment of cement sludge
DK1008558T3 (en) Process for the treatment of organic wastewater
DK0912603T3 (en) Process for the preparation of certain azacyclohexapeptides
DK1085900T3 (en) Use of erythropoietin for the treatment of primary haemochromatosis
DK0904070T3 (en) Use of the buckminster fuller for the treatment of neurotoxic lesions
NO984189D0 (en) Procedure for the treatment of bipolar disorder
DK1011678T3 (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
DK0951289T3 (en) Use of Mycobacterium vaccae for the treatment of chronic fatigue syndrome
DK1012152T3 (en) Process for the preparation of oxazaphosphorin-2-amines
DK0964681T3 (en) Anticonvulsant derivatives for the treatment of psoriasis
DK1493442T3 (en) Reboxetine for the treatment of peripheral neuropathy
DK0737068T3 (en) 2,3-diaryl-1-benzopyrans for the treatment of dermatitis
DK0889014T3 (en) Process for the treatment of sludge
DK0882035T3 (en) Process for the preparation of 2H-1-benzopyrans
KR960014504U (en) Sewage Treatment Centrifuge